These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29366302)

  • 21. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA; Donoso G; Moraga-Cid G; Folch H; Céspedes S; Andrews E
    Infect Immun; 2005 Jun; 73(6):3294-300. PubMed ID: 15908354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Brucella abortus DNA vaccine by expression of Cu-Zn superoxide dismutase antigen fused to IL-2.
    González-Smith A; Vemulapalli R; Andrews E; Oñate A
    Immunobiology; 2006; 211(1-2):65-74. PubMed ID: 16446171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective efficacy of a
    Kim WK; Moon JY; Cho JS; Hur J
    Can J Vet Res; 2019 Oct; 83(4):261-266. PubMed ID: 31571725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species.
    Mohammadi E; Golchin M
    Comp Immunol Microbiol Infect Dis; 2020 Jun; 70():101470. PubMed ID: 32208191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.
    Surendran N; Sriranganathan N; Lawler H; Boyle SM; Hiltbold EM; Heid B; Zimmerman K; Witonsky SG
    Vaccine; 2011 Mar; 29(15):2749-55. PubMed ID: 21316499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
    Tadepalli G; Konduru B; Murali HS; Batra HV
    Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection.
    Fu S; Xu J; Li X; Xie Y; Qiu Y; Du X; Yu S; Bai Y; Chen Y; Wang T; Wang Z; Yu Y; Peng G; Huang K; Huang L; Wang Y; Chen Z
    PLoS One; 2012; 7(2):e29552. PubMed ID: 22383953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB/c mice.
    Li X; Xu J; Xie Y; Qiu Y; Fu S; Yuan X; Ke Y; Yu S; Du X; Cui M; Chen Y; Wang T; Wang Z; Yu Y; Huang K; Huang L; Peng G; Chen Z; Wang Y
    Vet Microbiol; 2012 Dec; 161(1-2):137-44. PubMed ID: 22854331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
    Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
    Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
    Bhattacharjee AK; Izadjoo MJ; Zollinger WD; Nikolich MP; Hoover DL
    Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models.
    Kwon AJ; Moon JY; Kim WK; Kim S; Hur J
    J Vet Med Sci; 2016 Nov; 78(10):1541-1548. PubMed ID: 27349900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escheriosomes entrapped DNA vaccine co-expressing Cu-Zn superoxide dismutase and IL-18 confers protection against Brucella abortus.
    Singha H; Mallick AI; Jana C; Isore DP; Goswami TK; Srivastava SK; Azevedo VA; Chaudhuri P; Owais M
    Microbes Infect; 2008; 10(10-11):1089-96. PubMed ID: 18602490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immuno-profiles of BALB/c mice inoculated with Salmonella vector delivering B-cell mitogen hydroxyproline epimerase.
    Lalsiamthara J; Lee JH
    Mol Immunol; 2018 Mar; 95():114-121. PubMed ID: 29433066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
    Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
    Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.
    Velikovsky CA; Cassataro J; Giambartolomei GH; Goldbaum FA; Estein S; Bowden RA; Bruno L; Fossati CA; Spitz M
    Infect Immun; 2002 May; 70(5):2507-11. PubMed ID: 11953389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective efficacy of a canine brucellosis vaccine candidate based on live attenuated Salmonella expressing recombinant Brucella BCSP31, Omp3b and SOD proteins in Beagles.
    Kim WK; Moon JY; Cho JS; Park BY; Hur J
    J Vet Med Sci; 2018 Sep; 80(9):1373-1379. PubMed ID: 30068897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Azizi M; Bouzari S
    J Biotechnol; 2020 Feb; 310():89-96. PubMed ID: 32017955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.